Dosage optimum

Laboratory-scale test procedures consisting of jar test studies have been used for years, and the test methodology developed is such that full-scale designs can be developed from these studies with a high degree of confidence. A jar test is a series of bench-scale laboratory procedures made on 1- or 2-1 water samples to determine the most effective water treatment method. Tests are performed to identify the most effective coagulants, optimum dosage, optimum pH, and most effective order in which to add various chemicals. 

The I I cleaning procedures as a whole, compared with household laundering, are characterized by huge variations in the composition of the soils, types of surface to which they adhere, cleaning time available, etc. The optimum choice of enzyme type and dosage level normally has to be established through a cooperation between the customer (end user), manufacturer of the detergent, and enzyme producer. 

Reactions between alum and the normal constituents of wastewaters are influenced by many factors hence, it is impossible to predict accurately the amount of alum that will react with a given amount of alkalinity, lime, or soda ash which may have been added to the wastewater. Theoretical reactions can be written which will serve as a general guide, but in general the optimum dosage in each case must be determined by laboratory jar tests. 

Each of the antiretroviral drugs used in combination therapy regimens should always be used according to optimum schedules and dosages. 

Vries et al. [3.59] described the development of a stable parenteral dosage form of the cytotoxic drug E 09. E 09 dissolves poorly in water and its solution is unstable. With the addition of 200 mg of lactose per vial containing 8 mg of E 09, an optimum formulation was developed with respect to solubility, dosage of E 09 and length of the freeze drying cycle. DSC studies have been used to select the most effective parameters. The freeze dried product remains stable for 1 year when stored at 4 °C in a dark environment. 

The optimum dosage of H2SiF6 was between 200 and 300 g/t. Floatability of niobium was the most sensitive mineral to the level of H2SiF6. 

Step 1 The dominant quality factors here are convenience and the ability to deliver the precise dosage for applications. Optimum HLB is an important factor for convenience (Table 2). As in example 1, an HLB value between 3 and 15 is desirable for the detergency property, preferably towards the high end to give clear appearance (Figure 1). Thus, HLB0p is set to be 15. 

In actual practice, it has been observed that different official compendia describe a number of detailed types of tests with a view to obtain a constant and regular check that might be possible to maintain the desired degree of optimum purity both in the pure pharmaceutical substances and the respective dosage-forms made therefrom. 

Future directions for research on hypericum may continue the work done in clinical efficacy. More specifically, studies may be of interest that examine its effects in treatment of more severe depression and different subtypes of depression. The comparative efficacy of different hypericum preparations could be further investigated, and optimum dosages need to be established (Linde et al. 1996). Further work is needed to compare hypericum s efficacy and side effects with those of the SSRIs or atypical antidepressants, because published studies to date have only compared it with tricyclics. 

Side effects and plasma phenylbutazone levels correlate, and according to Bruck et al. (B28) the critical level is about 100 iig/m. Above this value the incidence of toxic effects increases markedly without further clinical improvement (cf. phenytoin). The suggestion by Bruck et al. (B28) that ideally phenylbutazone dosage should be adjusted to maintain optimum blood therapeutic levels has not been generally adopted, partly because of the tediousness of assays on a routine basis, and partly because their value as an aid to regulation of treatment has not been well appreciated. 

Jl, J4, T6). Little benefit can be demonstrated at lower plasma levels. In one study adjustment of dosage to maintain steady-state plasma theophylline levels within a recommended optimum therapeutic range of 10-20 /ig/ml led to improved therapeutic control (J4). To achieve this a more than 8-fold difference in the daily dose was necessary (J4), due to variations between one subject and another in the rate of metabolic degradation of theophylline. 

Tabiets, immediate-reiease Start with 30 mg 4 times/day before meals and at bedtime gradually increase dosage to 180 to 360 mg (given in divided doses 3 or 4 times/day) at 1- to 2-day intervals until optimum response is... 

---